This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Compugen Ltd. Corporation. Active years: 1997-2004.
Company Filing History:
2 out of 910 
1 out of 62 
Years Active: 1997-2004
Title: Idit Azar: Innovator in Nucleic Acid and Protein Production Technologies
Introduction
Idit Azar is a notable inventor based in Rehovot, Israel. He has made significant contributions to the fields of molecular biology and biotechnology. With a total of 3 patents, his work focuses on innovative solutions for nucleic acid and protein production.
Latest Patents
Idit Azar's latest patents include groundbreaking inventions in the area of nucleic acid sequences. One of his patents describes an isolated nucleic acid sequence that is an alternative splice variant of the human kallikrein-2 gene (KLK-2). This invention provides an expression vector containing the splice variant and a host cell transfected by the expression vector. The nucleic acid is particularly useful for determining the levels of nucleic acid sequences of human kallikrein variants in biological samples. Another significant patent relates to an expression vector that controls the production of recombinant peptides or proteins when the temperature is lowered in a bacterial host. This invention also encompasses host cells containing the vectors and methods for producing recombinant proteins.
Career Highlights
Throughout his career, Idit Azar has worked with prominent organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Compugen Ltd. Corporation. His work in these companies has allowed him to advance his research and contribute to the scientific community.
Collaborations
Idit Azar has collaborated with esteemed colleagues, including Amos B. Oppenheim and Hilla Giladi, who is a talented woman in the field. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Idit Azar's innovative work in nucleic acid and protein production technologies showcases his dedication to advancing scientific knowledge. His patents reflect a commitment to developing practical solutions that can benefit various applications in biotechnology.